Friday, May 20, 2016 9:57:41 AM
If you compare that to the trial of DNX-2401 http://neuro-oncology.oxfordjournals.org/content/16/suppl_3/iii39.2.abstract DCVax-L http://www.nwbio.com/NWBT_ITOC_poster_3-25-15.pdf IL-12 http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=971714 or even single agent checkpoint blockade http://global.onclive.com/web-exclusives/targeted-immunotherapy-on-horizon-for-brain-tumors then there are better things out there.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM